The role of smoking in the mechanisms of development of chronic obstructive pulmonary disease and atherosclerosis

S Kotlyarov - International Journal of Molecular Sciences, 2023 - mdpi.com
Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …

The impact of insulin resistance on the association between metabolic syndrome and lung function: the Kangbuk Samsung Health Study

J Lee, HK Park, MJ Kwon, SY Ham, HI Gil… - Diabetology & Metabolic …, 2023 - Springer
Abstract Background/Objective Metabolic syndrome (MS) is related to lung dysfunction.
However, its impact according to insulin resistance (IR) remains unknown. Therefore, we …

Not All Quiet on the Atherosclerosis Front

K Schäfer - International Journal of Molecular Sciences, 2023 - mdpi.com
In recent decades, research has identified the key cellular processes that take place during
atherosclerotic plaque development and progression, including endothelial dysfunction …

El eje cardiopulmonar y la mortalidad cardiovascular en el paciente EPOC

AC Montero - Medicina de Familia. SEMERGEN, 2023 - Elsevier
La enfermedad pulmonar obstructiva crónica (EPOC) es la cuarta causa de mortalidad en
nuestro medio y habitualmente se consideraba circunscrita al territorio pulmonar. Los …

Cardiovascular comorbidities and clinical outcomes in a cohort of adults with COPD in Jos, Nigeria: A prospective analytical study

GA Amusa, BI Awokola, AF Okoh, MO Akanbi… - Highland Medical …, 2024 - ajol.info
Background: Chronic obstructive pulmonary disease (COPD) is a significant contributor to
morbidity and mortality worldwide. Cardiovascular diseases (CVD) are a leading but under …

[PDF][PDF] Evaluation of the Cardiac Status of Newly Diagnosed Chronic Obstructive Pulmonary Disease Patients at First Admission

Mİ Bardakci, MA Ozkarafakili, MC Sumerkan - Indian Journal of Respiratory …, 2024 - ijrc.in
Objective: We aimed to detect possible cardiac pathologies early by cardiologically
evaluating patients newly diagnosed with chronic obstructive pulmonary disease (COPD) …

[HTML][HTML] Comorbidities of COPD: Mechanisms and Treatment. Update 2023

V Stratev, OM Fjeldstad - Medical Research Archives, 2023 - esmed.org
Chronic obstructive pulmonary disease (COPD) is chronic disease that affects mostly the
lungs but there is growing evidence that it is also a systemic condition associated with a …

Evaluation of Speckle-Tracking Echocardiography in COPD Patients Without Comorbidities

MC Sumerkan, MI Bardakci, MA Ozkarafakili… - Iranian Heart …, 2024 - journal.iha.org.ir
Background: Chronic obstructive pulmonary disease (COPD) and heart failure represent 2
entities of a growing global burden that share common clinical and etiological …

Evaluación del riesgo cardiovascular mediante tres escalas en una cohorte de pacientes suramericanos con EPOC

DM Villamizar, LA Dulcey-Sarmiento… - Gaceta Médica de …, 2024 - saber.ucv.ve
Introducción: Se prevé que la enfermedad pulmonar obstructiva crónica (EPOC) sea la
tercera causa de muerte en todo el mundo para 2030, se considera que el riesgo …

Хронічне обструктивне захворювання легень та синдром нічного апное–мультидисциплінарна проблема клінічної медицини

Н Чаплинська, В Рудник, Т Гавриш… - Сімейна …, 2023 - family-medicine.com.ua
Анотація Синдром обструктивного апное сну (СОАС) і хронічне обструктивне
захворювання легень (ХОЗЛ) є двома досить поширеними в клінічній практиці …